Press Releases

Giuseppe Aminzade joins Hogan Lovells as head of the Life Sciences regulatory department in Italy

Milan, 5 July 2021 – The international law firm Hogan Lovells announced today that Giuseppe Aminzade joined Hogan Lovells as Counsel, Head of the Life Sciences regulatory department...

Press Releases

Hogan Lovells advises Soliton in US$550 million acquisition by AbbVie's Allergan Aesthetics

Washington D.C., 13 May 2021 – Global law firm Hogan Lovells advised medical device company Soliton in its definitive agreement under which Allergan Aesthetics, an AbbVie company, will...

Press Releases

Hogan Lovells examines opportunities and challenges ahead for the life sciences and health care industry in new global guide

Washington, D.C., 25 February 2021 – Global law firm Hogan Lovells has published its fourth annual Life Sciences and Health Care Horizons report, an in-depth assessment of current...

Announcements

Hogan Lovells assists EyePoint Pharmaceuticals on transformative follow-on public offering of common stock

Philadelphia, Pennsylvania, 9 February 2021 – A team from global law firm Hogan Lovells has advised EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing...

Press Releases

Andreas von Falck takes the helm as Health & Lifestyle Sector Group Leader at Hogan Lovells, shepherding in a new leadership team for Life Sciences & Health Care

Washington, D.C., London, 25 January 2021 – Global law firm Hogan Lovells has today announced that Andreas von Falck will assume the role of Health & Lifestyle Sector Group Leader.

Press Releases

Hogan Lovells announces changes to office, practice area, and industry sector leadership roles

London and Washington, D.C., 30 June 2020 – Global law firm Hogan Lovells announces today it has made a series of planned changes to some of its office, practice area, and industry...

Press Releases

Hogan Lovells represents OptiNose in public offering

Philadelphia, 12 June 2018 – Hogan Lovells advised OptiNose, Inc., a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and...

Press Releases

Hogan Lovells represents Sesen Bio in public offering

Philadelphia, 6 June 2018 – Hogan Lovells advised Sesen Bio, Inc., a late-stage clinical company developing next-generation antibody-drug conjugate therapies for the treatment of...

Loading data